Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON38171
NL-OMON38171
Completed
N/A

HYBRID SIROLIMUS-ELUTING STENT WITH BIORESORBABLE POLYMER VERSUS EVEROLIMUS-ELUTING STENT WITH DURABABLE POLYMER FOR TOTAL OCCLUSIONS IN NATIVE CORONARY ARTERIES Primary Stenting of Occluded Native Coronary Arteries IV (PRISON IV) - PRISON IV

Sint Antonius Ziekenhuis0 sites250 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsangina pectorisstenosis of coronary arteries10011082

Overview

Phase
N/A
Intervention
Not specified
Conditions
angina pectoris
Sponsor
Sint Antonius Ziekenhuis
Enrollment
250
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\) the estimated duration of the occlusion is at least 4 weeks.
  • •2\) signs of ischemia related to the occluded coronary artery.
  • •3\) successful recanalization of the occluded artery is achieved.

Exclusion Criteria

  • •1\) primary or rescue PCI for acute myocardial infarction
  • •2\) the lesion could not be crossed.
  • •3\) lesions with complex anatomy making successful stent deployment unlikely.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Unknown
N/A
Biomime Stent in All-comers PCI Patients RegistryCoronary Artery Disease
NCT02398955Azienda Ospedaliero Universitaria Maggiore della Carita250
Withdrawn
N/A
Combo Bio-Engineered Sirolimus Eluting Stent Placement Long-Term Healing Pattern Assessment by Optical Coherence Tomographyincidence of intracoronary thrombi and late lossneointimal morphologyStrut coverage (binary and thickness)strut malapposition10011082
NL-OMON41146Academisch Medisch Centrum40
Active, Not Recruiting
N/A
IMUS ELUTED FROM A DURABLE VERSUS ERODABLE STENT COATING - LEADERS
EUCTR2006-001540-31-NLBIOSENSORS EUROPE SA1,700
Recruiting
N/A
Everolimus-eluting Bioresorbable Scaffolds for Treatment of Coronary Artery Disease in Patients with Diabetes Mellitus.International, Multicenter, Observational, Prospective Registry StudyDiabetes Mellitus, Coronary Artery Disease
NL-OMON26216Isala Clinics Zwolle500
Not Yet Recruiting
N/A
MULTIPURPOSE TOE SEPARATOR IN SKIN DISEASESHealth Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified
CTRI/2023/06/054202Father muller Research centre